McKesson is a healthcare services and information technology company. The Company distributes branded and generic pharmaceutical drugs, and other healthcare-related products, and provides practice management, technology, clinical support, and business solutions. It also provides specialty pharmaceutical solutions, medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, McKesson Corporation operates retail pharmacy chains, as well as supports independent pharmacy networks, and supplies integrated pharmacy management systems, automated dispensing systems, and related services. Further, the Company provides clinical, financial, and supply chain management solutions to healthcare organizations.

Type
Public
HQ
San Francisco, US
Founded
1833
Size (employees)
78,000 (est)
McKesson was founded in 1833 and is headquartered in San Francisco, US
Report incorrect company information

Key People/Management at McKesson

John Hammergren

John Hammergren

Chairman, President and Chief Executive Officer
Kathy McElligott

Kathy McElligott

Executive Vice President, Chief Information Officer and Chief Technology Officer
Jorge Figueredo

Jorge Figueredo

Executive Vice President, Human Resources
Lori Schechter

Lori Schechter

Executive Vice President, General Counsel and Chief Compliance Officer
Bansi Nagji

Bansi Nagji

Executive Vice President, Corporate Strategy and Business Development
Britt Vitalone

Britt Vitalone

Executive Vice President and Chief Financial Officer

McKesson Office Locations

McKesson has offices in London, Holon, Dublin, Buffalo and in 29 other locations
San Francisco, US (HQ)
McKesson Plaza 1 Post St
Alpharetta, US
5995 Windward Pkwy
Farmington, US
1690 New Britain Ave
Irvine, US
22 Corporate Park
King of Prussia, US
475 Allendale Rd
Livonia, US
30881 Schoolcraft Rd
Show all (36)
Report incorrect company information

McKesson Financials and Metrics

McKesson Financials

McKesson's revenue was reported to be $208.36 b in FY, 2018
USD

Revenue (FY, 2018)

208.4 b

Gross profit (FY, 2018)

11.2 b

Gross profit margin (FY, 2018), %

5.4%

Net income (FY, 2018)

297 m

EBIT (FY, 2018)

762 m

Market capitalization (25-May-2018)

30.1 b

Closing share price (25-May-2018)

145.8

Cash (31-Mar-2018)

2.7 b

EV

35.3 b
McKesson's current market capitalization is $30.1 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

137.6 b179 b190.9 b208.4 b

Revenue growth, %

30%7%

Cost of goods sold

129.3 b167.6 b179.5 b197.2 b

Gross profit

8.3 b11.4 b11.4 b11.2 b
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

33 b34.3 b44.1 b44.8 b47 b49.7 b50 b50.1 b51.1 b52.1 b

Cost of goods sold

30.9 b32.5 b41.3 b41.8 b44.1 b46.8 b47.2 b47.3 b48.5 b49.2 b

Gross profit

2 b1.8 b2.8 b2.9 b2.9 b2.9 b2.8 b2.8 b2.6 b2.8 b

Gross profit Margin, %

6%5%6%7%6%6%6%6%5%5%
Annual
usdY, 2010Y, 2011Y, 2012Y, 2013FY, 2014FY, 2015FY, 2016FY, 2018

Cash

3.7 b3.6 b3.1 b2.5 b4.2 b5.3 b4 b2.7 b

Inventories

16.3 b

Current Assets

32.6 b36.7 b38.4 b37.1 b

PP&E

2.2 b2 b2.3 b2.5 b
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

3 b2.4 b4.1 b3.8 b4.6 b4.7 b5.5 b2.4 b2.3 b2.6 b

Inventories

10.5 b11.5 b14.1 b14.1 b15.4 b15.5 b15.3 b16.1 b15.5 b16.9 b

Current Assets

24.5 b25.2 b34 b33.9 b37.1 b39 b41.3 b39.3 b37.7 b39.8 b

PP&E

1.3 b1.4 b2.2 b2.2 b2.2 b2.4 b2.3 b2.4 b2.3 b2.3 b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

1.3 b1.5 b2.3 b297 m

Depreciation and Amortization

951 m

Inventories

(1.2 b)(2.1 b)(1.3 b)(458 m)

Cash From Operating Activities

3.1 b3.1 b3.7 b4.3 b
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015

Net Income

404 m64 m411 m477 m511 m
USDY, 2018

EV/EBIT

46.3 x

EV/CFO

8.1 x

Revenue/Employee

2.7 m

Financial Leverage

6 x
Show all financial metrics

McKesson Operating Metrics

FY, 2016

Distribution Centers

2

Pharmacies Owned

2.20 k

Pharmacies Served

65 k
Show all operating metrics

McKesson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
CoverMyMeds (391)January 25, 2017$1.10 b
HealthQx July 12, 2016
Vantage Oncology April 04, 2016$525 m
UDG Healthcare September 16, 2015$432.21 m
McKesson Europe October 24, 2013$5.40 b
Ewendo November 06, 2012
MedVentive September 24, 2012
peerVue February 08, 2012
Portico Systems June 22, 2011
RelayHealth June 30, 2006
Report incorrect company information